Test results are the driving factor behind optimal therapy decisions for most patients.
Accelerate Pheno™ leverages multiple technologies to speed up identification and antibiotic susceptibility results.
The automated processing tracks the size, shape, and division rate of live cells forming into microcolonies while being challenged by antibiotics – all this and more with a simple kit and a highly functioning system!
Antibiotic
susceptibility
Optimise
Antibiotic therapy
Powered by
MCA(Morphokinetic Cellular Analysis)
Sample, dilution,
cell capture
An overview of the Accelerate Pheno™ Systems
Sample Vial
48-channel disposable test cassette
Regent Cartridge
which comes with a spill-proof cap
with 48 flowcells for multiplex testing
with reagents and media for more than 100 cleared assays
Save time by eliminating many of the sample preparation steps required prior to testing. The system makes these and other processes hands-free:
Identification methods rely on purified samples of one organism and 24-hour subculturing before testing. Other techniques fail with mixed bacteria samples or cover only a few species.
The Accelerate Pheno™ system offers fully automated simultaneous fluorescence in situ hybridization (FISH) tests. A signal from a target probe is compared with signal from universal bacterial and eukaryotic probes.
Morphokinetic Cellular Analysis (MCA) – Antibiotic susceptibility results are reported as MICs, and are determined by measuring morphokinetic changes in cell and colony growth in the presence of select concentrations of antibiotics.
The growth patterns are compared to reference growth profiles which have been correlated to broth microdilution MICs. Results are then interpreted based on interpretive breakpoints and expert rules.
User Interface and Informatics
Dashboard to LIS Reporting